Insider sale notice: Sammy Khalifa Class A shares

Sammy Khalifa reported intent to sell Class A common stock with a listed sale date of 03/02/2026 described as a Restricted Stock Lapse.

Rhea-AI Filing Summary

Sammy Khalifa reported intent to sell Class A common stock with a listed sale date of 03/02/2026 described as a Restricted Stock Lapse. The excerpt also lists prior securities sold in the past three months: 239 shares on 12/03/2025 and 754 shares on 02/20/2026.

This Form 144 notice names the security as Class A Common Stock and shows broker details for UBS Financial Services. The filing is a routine insider disposition notice stating planned and recent transactions; timing and proceeds detail beyond the dates and share counts above are not shown in the excerpt.

Insights

Compliance Counsel

Routine insider Form 144 notes planned sale tied to restricted stock lapse on 03/02/2026.

The excerpt lists a planned sale described as a Restricted Stock Lapse on 03/02/2026 and prior dispositions of 239 shares (12/03/2025) and 754 shares (02/20/2026). Broker information for UBS Financial Services is present.

These notices are procedural; the actual sale execution, price, and cash‑flow recipient are not shown in the excerpt. Subsequent filings or trade reports would confirm execution and aggregate proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the RBOT Form 144 excerpt show about the planned sale?

The excerpt shows a planned sale of Class A common stock described as a Restricted Stock Lapse with a listed date of 03/02/2026. It identifies the security class and the broker, but not the sale price or proceeds.

How many shares were reported sold in the past three months in this excerpt?

The excerpt lists prior dispositions of 239 shares on 12/03/2025 and 754 shares on 02/20/2026. Those counts appear in the "Securities Sold During The Past 3 Months" section.

Who is the reported selling party in the provided excerpt?

The filing names Sammy Khalifa as the reporting person tied to the listed transactions. Broker details include UBS Financial Services Inc at the Weehawken, NJ address shown in the excerpt.

Does the excerpt state the sale price or proceeds for the planned sale?

No. The excerpt provides dates, share counts, and sale type (Restricted Stock Lapse) but does not disclose any sale price, aggregate proceeds, or execution confirmation for the 03/02/2026 entry.

What should I look for to confirm the sale executed after this Form 144?

Check subsequent broker trade reports or Form 4/Form 5 filings for execution details. Look for reported sale price, number of shares sold, and the filing that confirms the 03/02/2026 transaction executed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 02:54 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001883777
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vicarious Surgical Inc
SEC File Number	001-39384
Address of Issuer	78 4th Ave Waltham MASSACHUSETTS 02451
Phone	6178681700
Name of Person for Whose Account the Securities are To Be Sold	Sammy Khalifa
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	276	530	5894273	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	03/02/2026	Restricted Stock Lapse	Vicarious Surgical Inc			695	03/02/2026	Restricted Stock Lapse

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	12/03/2025	239	668
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	02/20/2026	754	1487

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for Sammy Khalifa
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)